Evaluation and selection of patients for Intra uterine insemination (IUI)

  • Post author:
  • Post category:blog

Dr. Rana Choudhary
(MBBS, DNB, DGO, DFP, DCR, FCPS, FICMCH, FICOG, MNAMS)

Masters in Reproductive Medicine & IVF (UK)

Consultant Obstetrician & Gynaecologist
Reproductive Medicine (Fertility) Specialist

Certified Personal Counsellor

Introduction

IUI is a procedure to treat infertility in which washed and prepared sperms are introduced into the woman’s uterus, with timed ovulation, with the aim of getting the maximum number and most motile sperms nearer to the ovum and achieving pregnancy. The history of intrauterine insemination (IUI) goes back to the 18th century when Scottish surgeon John Hunter performed an effective procedure with the use of the husband’s sperm. In 1884, after William Pankhurst from Philadelphia in the United States applied the donor’s sperm, live birth was reported. ESHRE data indicate that the pregnancy rate per cycle (PR per cycle) after IUI-H is 12.4% compared with 28.9% after IVF and the results have not changed over the last few years.

History taking:

Various important point during history taking are summarized in the table below

Table 1: Important points to be considered during history taking of a couple presenting with infertility

 Sr.   No. Factor Specific findings/ questions   Importance
  1 Name   For identification of the patient Better rapport
  2 Age, Duration of infertility To decide the approach More the age and duration of infertility, more aggressive is the approach as chances of conception goes on decreasing
  3 Occupation Shift duties etc Decrease in frequency of intercourse
  4 Sexual history   Vaginusmus, Sexual satisfaction etc Decrease in frequency of intercourse
  5 Obstetric history H/o previous abortions, RPL, D & C Endometrium may be defective
  6 Medical history h/o DM, HT, Kochs, Thyroid problems Pregnancy may be high risk
  7 Surgical history H/o surgeries in pelvis and abdomen Adhesions leading to altered tubo-ovarian anatomy

Other aspects :

  • Both partners should be seen together
  • Privacy & sufficient clinical time

Positive predictive factors for IUI success           

  • Age of female partner < 35 years {should we consider a lower age (33years) for Indian women as their ovarian reserve gets depleted earlier?}
  • Duration of infertility < 5 years
  • At least one functional normal fallopian tube and no uterine factor leading to infertility
  • Adequate ovarian reserve (based on Sr. AMH, Antral follicular count, Day 2 FSH)
  • Good semen parameters

Variables affecting IUI success

Treatment with ovulation induction and IUI is more successful in an-ovulatory women. Various factors affect the success rate of IUI.

  1. Age of female -As age advances the chances of pregnancy after ovulation induction and assisted reproductive procedures (ART) procedures like IUI decreases.
  2. Unexplained Infertility – Addition of IUI to super ovulation produces better results than super ovulation and timed intercourse (11.37%) especially in cases of unexplained infertility.
  3. Endometriosis – Mild or minimal endometriosis may benefit from IUI (pregnancy rates 7% to 18%), however in severe cases it is not advisable (4.5%).
  4. Cervical Factor – Conception rate in natural cycle is 14% and in IUI plus Gonadotrophins is 17%.
  5. Male factor infertility –Total motile sperm count (TMSC) >5 million/ml and sperm morphology are most valuable sperm parameters to predict IUI outcome.

When To Start Investigations & Treatment?

Table 2: When to start investigations in of a couple presenting with infertility

 Sr.   No. Parameters When to start investigation
   1 <35 Years 1 Year
  2 >35 Years 6 Months
  3 40 Years & above At the earliest
  4 Oligomenorrhoea At the earliest
  5 Amenorrhoea At the earliest
  6 Abnormal pelvic ultrasonography At the earliest
  7 History suggestive of ↓ ovarian reserve At the earliest
  8 H/o previous surgeries eg salpingectomy or disease such as Kochs abdomen At the earliest

Ideal Body Weight (IBW)

Studies have shown that increased body weight / obesity interferes with ovulation & causes infertility

Calculate IBW using Brocas index

Males: (wt in kg) = Height (in cm) – 100

Females: (wt in kg) = Height (in cm) – 105

Table 4: Classification of obesity

Sr. No Body weight Type of obesity
   1 20% > Ideal body weight (IBW) Obese
   2 Body weight > 200 lbs  Morbidly obese 
   3  > 2 x Ideal body weight (IBW) Morbidly obese 

Table 5: Evaluation of Female Partner for infertility

 Sr.   No. Evaluation of  Test Importance
  1 Ovulatory function TSH, Prolactin, AMH, TVS Distinguish between ovulatory & non ovulatory women   AMH – To know ovarian reserve
  2 Pelvic Structure Detailed transvaginal ultrasound Detect structural abnormalities like poly, fibroid, cysts etc
  3 Tubal patency testing   HSG/ Laparoscopy / Hysteroscopy Extremely important before IUI

Flowchart 1: Management of thyroid abnormalities

https://drranachoudhary.com/wp-content/uploads/2020/03/Untitled.png 

Direct beneficial effect of TSH on follicular recruitment warrants investigation of serum thyroid levels and thyroxin supplementation in infertile women with Sr. TSH  ≥2.5 units in attempts to improve recruitment.

Table 6: Insulin resistance and infertility

  Insulin resistance (IR)  
  Measurement of Insulin resistance Fasting glucose (mmol/L) ÷ Fasting Insulin (micro IU/ml)
  IR Ratio < 4.5 Indicates Insulin resistance (IR)
  For eg.  FBS = 100   &   Fasting   Insulin is 45 Ratio = 100 ÷ 45 = 2.22 Indicates  Increased Insulin Resistance  

Anti Mullerian Hormone (AMH) test :

  • Produced by Preantral & small antral stage (< 4 mm)
  • No AMH is secreted by follicles > 8 mm
  • Can be measured on any day of cycle but better on day 2/3
  • Measurement of AMH = Biological Body Clock Test
  • Predicting live birth outcome, ovarian response & OHSS
  • May reflect fertility potential more accurately than conventional markers like FSH, inhibin B or estradiol levels
  • Should be done from a GOOD STANDARDISED LABORATORY as lab to lab variation is marked !
  • Relatively poor predictor for Pregnancy outcomes
  • Low AMH levels in isolation do not represent an appropriate marker for withholding treatment

Table 7: Importance of Anti Mullerian Hormone (AMH) test

  Sr. No. Sr. AMH levels Significance
   1 < 0.3  ng/ml Few eggs remaining    
   2 >2.5 ng/mL  Probably normal reserve 
   3 > 3.6 ng/mL Increased risk OHSS  

Ovarian reserve markers / tests

Age related decline in female fertility  well recognised. It starts at 30 years with rapid decline after 37 years. Commonly used ovarian reserve tests are :
D2 antral follicle count (<5 ,Poor outcome)

  • AMH of 2 to 6 (<1 Poor ovarian reserve, >6 PCO)
  • D2 FSH   > 10  IU/l  poor response to ART
  • No evidence for ovarian volume, ovarian blood flow, inhibin B, estradiol (E2)

Table 8: Possible factors suggestive of Poor Ovarian Reserve OR  Pre mature ovarian aging

  • Short follicular phase
  • Past h/o of surgeries – Endometriosis, ovarian cysts, adhesions
  • AFC less
  • Low AMH
  • P/h/o poor response to treatment

Table 9: Investigations to evaluate tubal patency

 Sr.   No. Investigation Advantages Disadvantages
  1 HSG Screening test Not very specific
    Ideal cost effective False positivity rate is high
    Non-invasive  
    Pre-operative help in counseling  
  Laparoscopy Gold standard Cost
    High specificity & sensitivity   Invasive

Conclusion:

  • Adequate & Compassionate Counseling
  • Do not bombard with investigations as it further increases stress in patients
  • Each patient is different, hence blanket treatment is not justified
  • Keep a watch on couples age …especially ovarian aging as chances of pregnancy decreases exponentially, as age of the female partner advances
  • Give patients an idea about real expectations/ results so that they can prepare themselves
  • Timely referral
  • Individualization is the key to success

Male  Factor Evaluation

  • Detailed history – Exposure to high temperature ,environmental toxins etc
  • Thorough clinical evaluation – esp in relation to any local genital / scrotal swelling eg. Varicocoele, Hydrocoele etc
  • Lab investigations

Fig 1 : Adverse Effects Of Obesity on Semen parameters  

  Excess peripheral adipose tissue (High aromatase activity) Testosterone → Estradiol Androstenedione → Estrone   Excess of suprapubic & inner thigh fat ­ scrotal temperatures   All these can cause ↓sperm count as well as motility  

Table 10: Physical Examination in males with infertility

 Sr   No. Factor Importance
  1 General examination Stature, Height ,Weight , BMI, BP  
  2 Increased BMI R/o DM
  3 TPR / BP R/o HT
  4 Gynecomastia Hormonal imbalance
  5 Hair distribution & amount Subvirilization
  6 Genital –  Spermatic cord, Scrotum, Testis (mobility, consistency), Abnormal shapes of penis, urethral meatus Only in indicated cases with abnormal semen analysis
  7 Azoospermia                                                                                            Rectal exam to exclude ejaculatory duct obstruction  

Table 11: Investigation of Male Partner for infertility 

 Sr   No. Factor Importance
  1 Detailed Semen Analysis-  Count, Motility and    Morphology   Treatment depends primarily on this report
  2 Viral markers –  HBsAg , HIV, HCV   Required for IUI
  3 Semen culture If semen analysis shows leucospermia
  4 Sperm Function Test     If semen analysis shows moderate to severe Oligoasthenozooteratospermia (OATS)
  5 Sr. FSH   If semen analysis shows moderate to severe Oligoasthenozooteratospermia (OATS)   To differentiate cause of AZOOSPERMIA –                 Obstructive   versus  Non Obstructive   Low in hypogonadotrophic hypogonadism  
  6 Sr. LH Low in hypogonadotrophic hypogonadism
  7 Sr. Testosterone   If semen analysis shows moderate to severe Oligoasthenozooteratospermia (OATS)  
  8 Sr Prolactin Erectile dysfunction
  9 Blood Sugar   DM
  10 Colour Doppler Clincial examination s/o  Varicocoele   If semen analysis shows moderate to severe Oligoasthenozooteratospermia (OATS)
  11 Karyotype   If semen analysis shows moderate to severe Oligoasthenozooteratospermia (OATS)
  12 Y chromosome Microdeletion If semen analysis shows moderate to severe Oligoasthenozooteratospermia (OATS)   H/o repeated implantation failure / abortions in first trimester

Semen Analysis

  • Cornerstone’ of  lab evaluation (although it is not a sperm function test)
  • Gives information – Functional status  of seminiferous tubules, epididymides & accessory sexual glands
  • Prostatic gland fluid (0.5ml – zinc, citric acid, acid phosphatase & proteases)- assures liquefaction
  • Seminal vesicle fluid (1.5-2ml -prostaglandins & fructose)
  • Semen sample must be collected after min 3 days & max 7 days of abstinence
  • Semen analysis – In Clinical Practice, male factor infertility is identified by ABNORMAL SEMEN PARAMETERS
  • Interpretation of semen analysis report
  • Only from a standardised laboratory
  • Any abnormal report must be confirmed by at least two reports, atleast  4 weeks apart
  • Judge  response to  treatments  after  3 months of therapy as one  spermatogenic   cycle (testicular)  lasts from 63  –  72 days 

Table 12: WHO (2010) guidelines for normal semen reporting

  Semen parameters Normal value
  Semen volume 1.5 ml
  Total sperm in the ejaculate 39 million
  Sperm per ml 15 million/ml
  Vitality 58% live
  Progressive motility 32 %
  Total motility 40 %
  Morphologically normal 4 %

Ref: World Health Organization. NICE guideline CG156, recommendation 1.3.1.1. Oct 2014

  Success of   IUI – Total  Motile Sperm Count (TMC)  & Morphology TMSC = Count x Volume x % Motility   eg   (10 million x 4 ml x 50) ÷  100  = TMC 20 million  

 

Table 13: Semen parameters and treatment required

  Sr. No. Semen parameters Treatment required
   1 5 Million (Pre wash count) IUI
   2 1 million (Postwash) IUI
   3 Pre wash 1-5 million IVF
   4 Pre wash <1 million ICSI

  • Success in IUI is highest with ≥ 14 % sperms with normal morphology, Intermediate  with  4 – 14 % and poor  with < 4 %

  Poor sperm count doesn’t rule out any pregnancy possibility Normal count doesn’t guarantee   fertilization/pregnancy

Table 14: Sperm Function Tests

 Sr.   No. Test Importance
  1 Hypo-osmotic swelling (HOS) test Integrity & behavior of the cell membrane of the sperm tail
    Helps to distinguish between immotile alive  & dead sperms
  2 Sperm DNA  Fragmentation Test   Sperm quality is dependent on  the amount of damage to the sperm DNA or DNA fragmentation

   Indication for Sperm Function Tests –

  • All men with abnormal semen analysis  
  • Advanced age
  • Infection
  • Normal semen analysis but failed IVF for unexplained reasons
  • May help predict success of a procedure

Table 15: Management tips during evaluation for Varicoele

 Sr.   no. Test Importance Management
  1 Grade 1 & 2 Varicoele No surgery is required A trail of medical therapy can be given, followed by IUI
  2 Grade 3 Surgical management Surgery
  3 Positive Predictive factors of varicocelectomy in grade 3 varicocoele Lack of testicular atrophy   Normal FSH   Total sperm count more than 5 million    

Table 16: Golden Rules For Investigations

  Clinically relevant and effectiveShould impact the line of treatmentEasy to interpretFeasible – cost,     convenienceInvestigations are seldom more important than the treatment or the res    

References:

  1. Diagnostic evaluation of infertile female: a committee opinion. The Practice Committee of the American Society for Reproductive Medicine. Fertility & Sterility,  Aug 2012.
  2. What affects functional ovarian reserve, thyroid function or thyroid autoimmunity? Reprod Biol Endocrinol. 2016 May.
  3. Med Pregl. 2016 Jan-Feb;69(1-2):25-30.
  4. What affects functional ovarian reserve, thyroid function or thyroid autoimmunity? Reprod Biol Endocrinol. 2016 May
  5. Evaluating the performance of serum antimullerian hormone concentration in predicting the live birth rate of controlled ovarian stimulation and intrauterine insemination. Fertil Steril. 2010 Nov
  6. World Health Organization. NICE guideline CG156, recommendation 1.3.1.1. Oct 2014